A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
Beteiligte Einrichtungen
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 4 |
| ISSN | 0887-6924 |
| Status | Veröffentlicht - 2008 |
| pubmed | 17851552 |
|---|
